RecruitingPhase 1Phase 2NCT07148999
An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera
An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for PPOS
Sponsor
Urmila DIwekar
Enrollment
200 participants
Start Date
Sep 23, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.
Eligibility
Sex: FEMALEMin Age: 20 YearsMax Age: 50 Years
Inclusion Criteria1
- infertile women
Exclusion Criteria1
- All female patients who will not undergo IVF or whose cycles will be converted to IUI. Male patients will not be enrolled in this study. No donor cycles.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
COMBINATION_PRODUCTOpt-IVF
Opt-IVF provides optimized dosage profile for each patient
OTHERControl
Physicians will decide the dosage for each day for patients
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07148999
Related Trials
Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility
NCT074049691 location
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
NCT0721674216 locations
Standardization of Variable Conditions of Embryo Transfer Into the Uterine Cavity in the Procedure of Medically Assisted Procreation in Humans
NCT073961811 location
Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential
NCT074563975 locations
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
NCT067461291 location